X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4653) 4653
Newsletter (456) 456
Newspaper Article (40) 40
Magazine Article (35) 35
Dissertation (17) 17
Book Chapter (16) 16
Conference Proceeding (7) 7
Publication (5) 5
Book Review (1) 1
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2948) 2948
science & technology (2873) 2873
life sciences & biomedicine (2782) 2782
pravastatin (2718) 2718
male (2166) 2166
pravastatin - therapeutic use (1789) 1789
female (1694) 1694
middle aged (1390) 1390
pravastatin - pharmacology (1046) 1046
aged (1037) 1037
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (916) 916
animals (898) 898
anticholesteremic agents - therapeutic use (879) 879
cardiovascular system & cardiology (870) 870
adult (820) 820
statins (797) 797
pharmacology & pharmacy (765) 765
cardiac & cardiovascular systems (691) 691
hypercholesterolemia - drug therapy (666) 666
abridged index medicus (665) 665
cholesterol, ldl - blood (585) 585
cholesterol (584) 584
simvastatin (583) 583
pravastatin - administration & dosage (579) 579
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (570) 570
cholesterol - blood (554) 554
antilipemic agents (540) 540
risk factors (511) 511
treatment outcome (500) 500
research (471) 471
peripheral vascular disease (412) 412
atorvastatin calcium (407) 407
rats (404) 404
pravastatin - adverse effects (396) 396
hypercholesterolemia (376) 376
double-blind method (362) 362
heptanoic acids - therapeutic use (355) 355
drug therapy (335) 335
atorvastatin (329) 329
general & internal medicine (327) 327
simvastatin - therapeutic use (326) 326
medicine, general & internal (320) 320
atherosclerosis (318) 318
lipids (316) 316
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (311) 311
anticholesteremic agents - pharmacology (309) 309
coronary heart disease (302) 302
pyrroles - therapeutic use (300) 300
triglycerides - blood (298) 298
hypercholesterolemia - blood (297) 297
analysis (290) 290
cardiovascular agents (288) 288
drugs (283) 283
hydroxymethylglutaryl-coa reductase inhibitors (282) 282
lipids - blood (279) 279
dose-response relationship, drug (277) 277
time factors (266) 266
follow-up studies (261) 261
mice (261) 261
cholesterol, hdl - blood (258) 258
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (254) 254
coronary disease - prevention & control (252) 252
prospective studies (249) 249
care and treatment (242) 242
anticholesteremic agents - administration & dosage (236) 236
statin (234) 234
lovastatin - therapeutic use (224) 224
low density lipoproteins (224) 224
health aspects (218) 218
randomized controlled trials as topic (216) 216
prevention (215) 215
hyperlipidemias - drug therapy (214) 214
cardiovascular diseases (210) 210
drug therapy, combination (209) 209
lovastatin - analogs & derivatives (208) 208
aged, 80 and over (207) 207
universities and colleges (207) 207
pravastatin - pharmacokinetics (205) 205
fluvastatin (204) 204
cells, cultured (201) 201
simvastatin - pharmacology (201) 201
cardiovascular disease (200) 200
lovastatin - pharmacology (197) 197
drug interactions (195) 195
biochemistry & molecular biology (194) 194
medical research (190) 190
cardiovascular diseases - prevention & control (187) 187
anticholesteremic agents - adverse effects (181) 181
hypercholesterolemia - complications (178) 178
heptanoic acids - pharmacology (169) 169
diabetes (165) 165
medicine, experimental (164) 164
coronary disease - drug therapy (163) 163
physiological aspects (162) 162
clinical trials as topic (156) 156
rats, sprague-dawley (153) 153
lovastatin (147) 147
hypertension (145) 145
nutritional and metabolic diseases (145) 145
cardiovascular (144) 144
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4868) 4868
Japanese (179) 179
German (80) 80
Spanish (65) 65
French (49) 49
Chinese (40) 40
Italian (36) 36
Portuguese (32) 32
Russian (16) 16
Czech (7) 7
Dutch (6) 6
Korean (6) 6
Norwegian (6) 6
Swedish (6) 6
Polish (5) 5
Danish (4) 4
Hungarian (3) 3
Finnish (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of obstetrics and gynecology, ISSN 0002-9378, 06/2016, Volume 214, Issue 6, pp. 720.e1 - 720.e17
Journal Article
Nature medicine, ISSN 1546-170X, 06/2008, Volume 14, Issue 7, pp. 767 - 772
Journal Article
International journal of pharmaceutics, ISSN 0378-5173, 12/2015, Volume 496, Issue 2, pp. 518 - 525
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 07/2016, Volume 134, Issue 2, pp. 114 - 125
Journal Article
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 12/2010, Volume 108, Issue 4, pp. 1451 - 1455
Preeclampsia is a relatively common pregnancy-related disorder. Both maternal and fetal lives will be endangered if it proceeds unabated. Recently, the... 
Hypertension | Pregnancy | Animal models | Reproduction | Placenta | Fetal growth retardation | Preeclampsia | Blastocyst | Blood pressure | Female animals | Hemolytic anemia, elevated liver enzymes, and low platelet count | Trophoblast | 3-hydroxy-3-methyl-glutaryl-CoA | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Pre-Eclampsia - genetics | Humans | Pregnancy Proteins - genetics | Male | Pregnancy Proteins - metabolism | Pre-Eclampsia - prevention & control | HEK293 Cells | Female | Lentivirus - genetics | Pre-Eclampsia - metabolism | Disease Models, Animal | Vascular Endothelial Growth Factor Receptor-1 - genetics | Animals, Newborn | Pravastatin - pharmacology | Cell Line | Transduction, Genetic | Injections, Intraperitoneal | Mice, Transgenic | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Placenta - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Pravastatin - administration & dosage | Placenta Growth Factor | Mice | Development and progression | Models | Dosage and administration | Drug therapy | Pravastatin | Vascular endothelial growth factor | Health aspects | Index Medicus | Biological Sciences | trophoblast | hemolytic anemia, elevated liver enzymes, and low platelet count
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2014, Volume 61, Issue 1, pp. 139 - 147
Journal Article
Canadian Medical Association journal (CMAJ), ISSN 0820-3946, 02/2015, Volume 187, Issue 3, pp. 174 - 180
Background: The cytochrome P450 3A4 (CYP3A4) inhibitor clarithromycin may also inhibit liver-specific organic anion-transporting polypeptides (OATP1B1 and... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Fluorobenzenes - pharmacokinetics | Organic Anion Transporters, Sodium-Independent - antagonists & inhibitors | Humans | Male | Pyrimidines - metabolism | Indoles - metabolism | Drug Interactions | Fatty Acids, Monounsaturated - therapeutic use | Fluvastatin | Hydroxymethylglutaryl-CoA Reductase Inhibitors - metabolism | Fatty Acids, Monounsaturated - metabolism | Aged, 80 and over | Female | Acute Kidney Injury - chemically induced | Retrospective Studies | Pravastatin - therapeutic use | Solute Carrier Organic Anion Transporter Family Member 1B3 | Fluorobenzenes - metabolism | Clarithromycin - adverse effects | Pravastatin - metabolism | Rosuvastatin Calcium | Sulfonamides - pharmacokinetics | Organic Anion Transporters | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Sulfonamides - metabolism | Hyperkalemia - chemically induced | Pyrimidines - pharmacokinetics | Rhabdomyolysis - chemically induced | Fatty Acids, Monounsaturated - pharmacokinetics | Indoles - pharmacokinetics | Indoles - therapeutic use | Aged | Liver-Specific Organic Anion Transporter 1 | Cytochrome P-450 CYP3A Inhibitors - adverse effects | Fluorobenzenes - therapeutic use | Pravastatin - pharmacokinetics | Complications and side effects | Clarithromycin | Pravastatin | Biopolymers | Cytochrome P-450 | Antilipemic agents | Prescription drugs | Side effects | Older people | Risk factors | Statins | Index Medicus | Abridged Index Medicus | Research
Journal Article